![]() |
|
|
Vol. 300, Issue 1, 291-297, January 2002
Escuela Universitaria (E.U.) Optica, Universidad Complutense de
Madrid, Madrid, Spain (J.P.); Departmento de Bioquimica, E.U. Optica,
Universidad Complutense, Madrid, Spain (A.P.); University College,
London, United Kingdom (C.H.V.H.); and Inspire Pharmaceuticals, Inc.,
Durham, North Carolina (C.R., J.D., I.S., B.Y.)
Extracellular diadenosine polyphosphates play important signaling
functions in a number of physiological responses. Here we show
that diadenosine polyphosphates are normal constituents of tear fluid
and are potent stimulators of tear secretion through their interaction
with P2Y receptors. Diadenosine tetraphosphate (Ap4A) and
Ap5A were found in rabbit tears under basal conditions at
concentrations of 2.92 and 0.58 µM, respectively. Single applications of UTP, ATP, and Ap4A increased tear secretion to 160 ± 8% (n = 16) (P < 0.001),
131 ± 6% (P < 0.05), and 162 ± 11%
(P < 0.05) of placebo values, respectively.
Ap4A, Ap5A, and Ap6A, but not Ap2A and Ap3A, were able to stimulate tear
secretion in a dose-dependent manner. Concentration-response studies
produced pD2 values of 5.56 ± 0.03, 5.75 ± 0.12, and 5.50 ± 0.09 for Ap4A, Ap5A, and Ap6A, respectively, with Ap4A showing the
greatest efficacy. Diadenosine polyphosphates also stimulated
P2Y1 and P2Y2 receptors expressed in 1321N1
cells with no apparent effect on the other P2Y receptors tested.
Nonselective P2 antagonists did not modify the tear secretion induced
by UTP or Ap4A in rabbit eyes in vivo or in cloned
receptors, except for a weak but significant reduction in stimulated
tear secretion by reactive blue 2. These results suggest that
diadenosine polyphosphates stimulate tear secretion via a P2Y
receptor-mediated mechanism. Comparing the effects of diadenosine
polyphosphates applied to the rabbit eye and to cloned P2Y receptors,
it appears that the P2Y2 receptor subtype is responsible
for the prosecretory effects of these compounds.
This article has been cited by other articles:
![]() |
A. Mediero, A. Guzman-Aranguez, A. Crooke, A. Peral, and J. Pintor Corneal Re-epithelialization Stimulated by Diadenosine Polyphosphates Recruits RhoA/ROCK and ERK1/2 Pathways Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4982 - 4992. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mediero, A. Peral, and J. Pintor Dual roles of diadenosine polyphosphates in corneal epithelial cell migration. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4500 - 4506. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Soto, J. Pintor, A. Peral, A. Gual, and X. Gasull Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1042 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwai, S. Kuramitsu, and R. Masui The Nudix Hydrolase Ndx1 from Thermus thermophilus HB8 Is a Diadenosine Hexaphosphate Hydrolase with a Novel Activity J. Biol. Chem., May 21, 2004; 279(21): 21732 - 21739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pintor, T. Pelaez, and A. Peral Adenosine Tetraphosphate, Ap4, a Physiological Regulator of Intraocular Pressure in Normotensive Rabbit Eyes J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 468 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leipziger Control of epithelial transport via luminal P2 receptors Am J Physiol Renal Physiol, March 1, 2003; 284(3): F419 - F432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pintor, A. Peral, T. Pelaez, S. Martin, and C. H. V. Hoyle Presence of Diadenosine Polyphosphates in the Aqueous Humor: Their Effect on Intraocular Pressure J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 342 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Yerxa, J. R. Sabater, C. W. Davis, M. J. Stutts, M. Lang-Furr, M. Picher, A. C. Jones, M. Cowlen, R. Dougherty, J. Boyer, et al. Pharmacology of INS37217 [P1-(Uridine 5')-P4- (2'-deoxycytidine 5')tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 871 - 880. [Abstract] [Full Text] [PDF] |
||||